Skip to main content
Erschienen in: Neurosurgical Review 2/2018

26.05.2017 | Original Article

Association between antithrombotic drug use before chronic subdural haematoma and outcome after drainage: a systematic review and meta-analysis

verfasst von: Michael T. C. Poon, Rustam Al-Shahi Salman

Erschienen in: Neurosurgical Review | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

In view of their age and vascular co-morbidities, people are often taking an antithrombotic drug when diagnosed with chronic subdural haematoma (CSDH). It is unclear whether antithrombotic use at CSDH diagnosis, or resumption afterwards, is associated with recurrent CSDH or vaso-occlusive events. We systematically reviewed the literature for studies reporting CSDH recurrence or vaso-occlusive events after drainage of CSDH associated with antithrombotic drug use. We searched Medline 1946–2016 and Embase 1974–2016 inclusive for cohort studies reporting the risk of CSDH recurrence or vaso-occlusive events after CSDH associated with antithrombotic (anticoagulant or antiplatelet) drug use. We meta-analysed outcome data using a random effect model and assessed inconsistency between studies using the I-squared (I 2) statistic. We found 20 studies reporting outcome after drainage of CSDH associated with antithrombotic drug use. Before CSDH drainage, 337 (11.5%) of 2941 patients in 12 studies used an anticoagulant drug and 600 (19%) of 3150 patients in 11 studies used an antiplatelet drug. The association between antithrombotic drug use and CSDH recurrence was significant for antiplatelet drug use (relative risk [RR] 1.36, 95% CI 1.05 to 1.75; I 2 = 36.3%), but marginally significant for anticoagulant drug use (RR 1.38 95% CI 1.00–1.91; I 2 = 37.5%). Two studies including 30 patients reported one vaso-occlusive outcome event after CSDH. Antithrombotic drug use at CSDH diagnosis may be associated with post-operative CSDH recurrence. It is unclear whether this is attributable to confounding factors, antithrombotic reversal strategies or antithrombotic drug resumption. Further observational studies and randomised controlled trials of antithrombotic drug resumption are needed.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Baechli H, Nordmann A, Bucher HC, Gratzl O (2004) Demographics and prevalent risk factors of chronic subdural haematoma: results of a large single-center cohort study. Neurosurg Rev 27:263–266CrossRefPubMed Baechli H, Nordmann A, Bucher HC, Gratzl O (2004) Demographics and prevalent risk factors of chronic subdural haematoma: results of a large single-center cohort study. Neurosurg Rev 27:263–266CrossRefPubMed
3.
Zurück zum Zitat Miranda LB, Braxton E, Hobbs J, Quigley MR (2011) Chronic subdural hematoma in the elderly: not a benign disease. J Neurosurg 114:72–76CrossRefPubMed Miranda LB, Braxton E, Hobbs J, Quigley MR (2011) Chronic subdural hematoma in the elderly: not a benign disease. J Neurosurg 114:72–76CrossRefPubMed
4.
Zurück zum Zitat Chari A, Clemente Morgado T, Rigamonti D (2014) Recommencement of anticoagulation in chronic subdural haematoma: a systematic review and meta-analysis. Br J Neurosurg 28:2–7CrossRefPubMed Chari A, Clemente Morgado T, Rigamonti D (2014) Recommencement of anticoagulation in chronic subdural haematoma: a systematic review and meta-analysis. Br J Neurosurg 28:2–7CrossRefPubMed
5.
Zurück zum Zitat Weigel R, Schmiedek P, Krauss JK (2003) Outcome of contemporary surgery for chronic subdural haematoma: evidence based review. J Neurol Neurosurg Psychiatry 74:937–943CrossRefPubMedPubMedCentral Weigel R, Schmiedek P, Krauss JK (2003) Outcome of contemporary surgery for chronic subdural haematoma: evidence based review. J Neurol Neurosurg Psychiatry 74:937–943CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Aspegren OP, Astrand R, Lundgren MI, Romner B (2013) Anticoagulation therapy a risk factor for the development of chronic subdural hematoma. Clin Neurol Neurosurg 115:981–984CrossRefPubMed Aspegren OP, Astrand R, Lundgren MI, Romner B (2013) Anticoagulation therapy a risk factor for the development of chronic subdural hematoma. Clin Neurol Neurosurg 115:981–984CrossRefPubMed
7.
Zurück zum Zitat Baraniskin A, Steffens C, Harders A, Schmiegel W, Schroers R, Spangenberg P (2014) Impact of pre-hospital antithrombotic medication on the outcome of chronic and acute subdural hematoma. J Neurol Surg 75:31–36CrossRef Baraniskin A, Steffens C, Harders A, Schmiegel W, Schroers R, Spangenberg P (2014) Impact of pre-hospital antithrombotic medication on the outcome of chronic and acute subdural hematoma. J Neurol Surg 75:31–36CrossRef
8.
Zurück zum Zitat Chon K-H, Lee J-M, Koh E-J, Choi H-Y (2012) Independent predictors for recurrence of chronic subdural hematoma. Acta Neurochir 154:1541–1548CrossRefPubMed Chon K-H, Lee J-M, Koh E-J, Choi H-Y (2012) Independent predictors for recurrence of chronic subdural hematoma. Acta Neurochir 154:1541–1548CrossRefPubMed
9.
Zurück zum Zitat Forster MT, Mathe AK, Senft C, Scharrer I, Seifert V, Gerlach R (2010) The influence of preoperative anticoagulation on outcome and quality of life after surgical treatment of chronic subdural hematoma. J Clin Neurosci 17:975–979CrossRefPubMed Forster MT, Mathe AK, Senft C, Scharrer I, Seifert V, Gerlach R (2010) The influence of preoperative anticoagulation on outcome and quality of life after surgical treatment of chronic subdural hematoma. J Clin Neurosci 17:975–979CrossRefPubMed
10.
Zurück zum Zitat Gonugunta V, Buxton N (2001) Warfarin and chronic subdural haematomas. Br J Neurosurg 15:514–517CrossRefPubMed Gonugunta V, Buxton N (2001) Warfarin and chronic subdural haematomas. Br J Neurosurg 15:514–517CrossRefPubMed
11.
Zurück zum Zitat Kawamata T, Takeshita M, Kubo O, Izawa M, Kagawa M, Takakura K (1995) Management of intracranial hemorrhage associated with anticoagulant therapy. Surg Neurol 44:438–442 discussion 443CrossRefPubMed Kawamata T, Takeshita M, Kubo O, Izawa M, Kagawa M, Takakura K (1995) Management of intracranial hemorrhage associated with anticoagulant therapy. Surg Neurol 44:438–442 discussion 443CrossRefPubMed
13.
Zurück zum Zitat Leroy HA, Aboukais R, Reyns N, Bourgeois P, Labreuche J, Duhamel A, Lejeune JP (2015) Predictors of functional outcomes and recurrence of chronic subdural hematomas. J Clin Neurosci 22:1895–1900CrossRefPubMed Leroy HA, Aboukais R, Reyns N, Bourgeois P, Labreuche J, Duhamel A, Lejeune JP (2015) Predictors of functional outcomes and recurrence of chronic subdural hematomas. J Clin Neurosci 22:1895–1900CrossRefPubMed
14.
Zurück zum Zitat Lindvall P, Koskinen L-OD (2009) Anticoagulants and antiplatelet agents and the risk of development and recurrence of chronic subdural haematomas. J Clin Neurosci 16:1287–1290CrossRefPubMed Lindvall P, Koskinen L-OD (2009) Anticoagulants and antiplatelet agents and the risk of development and recurrence of chronic subdural haematomas. J Clin Neurosci 16:1287–1290CrossRefPubMed
15.
Zurück zum Zitat Ohba S, Kinoshita Y, Nakagawa T, Murakami H (2013) The risk factors for recurrence of chronic subdural hematoma. Neurosurg Rev 36:145–149 discussion 149-150CrossRefPubMed Ohba S, Kinoshita Y, Nakagawa T, Murakami H (2013) The risk factors for recurrence of chronic subdural hematoma. Neurosurg Rev 36:145–149 discussion 149-150CrossRefPubMed
16.
Zurück zum Zitat Okamura A, Kawamoto Y, Sakoda E, Murakami T, Hara T (2013) Evaluation of recurrence factors and Gorei-san administration for chronic subdural hematoma after percutaneous subdural tapping. Hiroshima J Med Sci 62:77–82PubMed Okamura A, Kawamoto Y, Sakoda E, Murakami T, Hara T (2013) Evaluation of recurrence factors and Gorei-san administration for chronic subdural hematoma after percutaneous subdural tapping. Hiroshima J Med Sci 62:77–82PubMed
17.
Zurück zum Zitat Okano A, Oya S, Fujisawa N, Tsuchiya T, Indo M, Nakamura T, Chang HS, Matsui T (2014) Analysis of risk factors for chronic subdural haematoma recurrence after burr hole surgery: optimal management of patients on antiplatelet therapy. Br J Neurosurg 28:204–208CrossRefPubMed Okano A, Oya S, Fujisawa N, Tsuchiya T, Indo M, Nakamura T, Chang HS, Matsui T (2014) Analysis of risk factors for chronic subdural haematoma recurrence after burr hole surgery: optimal management of patients on antiplatelet therapy. Br J Neurosurg 28:204–208CrossRefPubMed
18.
Zurück zum Zitat Phang I, Sivakumaran R, Papadopoulos MC (2015) No association between seniority of surgeon and postoperative recurrence of chronic subdural haematoma. Ann R Coll Surg Engl 97:584–588CrossRefPubMedPubMedCentral Phang I, Sivakumaran R, Papadopoulos MC (2015) No association between seniority of surgeon and postoperative recurrence of chronic subdural haematoma. Ann R Coll Surg Engl 97:584–588CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Stanisic M, Lund-Johansen M, Mahesparan R (2005) Treatment of chronic subdural hematoma by burr-hole craniostomy in adults: influence of some factors on postoperative recurrence. Acta Neurochir 147:1249–1256 discussion 1256-1247CrossRefPubMed Stanisic M, Lund-Johansen M, Mahesparan R (2005) Treatment of chronic subdural hematoma by burr-hole craniostomy in adults: influence of some factors on postoperative recurrence. Acta Neurochir 147:1249–1256 discussion 1256-1247CrossRefPubMed
20.
Zurück zum Zitat Torihashi K, Sadamasa N, Yoshida K, Narumi O, Chin M, Yamagata S (2008) Independent predictors for recurrence of chronic subdural hematoma: a review of 343 consecutive surgical cases. Neurosurgery 63:1125–1129 discussion 1129CrossRefPubMed Torihashi K, Sadamasa N, Yoshida K, Narumi O, Chin M, Yamagata S (2008) Independent predictors for recurrence of chronic subdural hematoma: a review of 343 consecutive surgical cases. Neurosurgery 63:1125–1129 discussion 1129CrossRefPubMed
21.
Zurück zum Zitat Tugcu B, Tanriverdi O, Baydin S, Hergunsel B, Gunaldi O, Ofluoglu E, Alatas I, Demirgil B, Emel E (2014) Can recurrence of chronic subdural hematoma be predicted? A retrospective analysis of 292 cases. J Neurol Surg 75:37–41 Tugcu B, Tanriverdi O, Baydin S, Hergunsel B, Gunaldi O, Ofluoglu E, Alatas I, Demirgil B, Emel E (2014) Can recurrence of chronic subdural hematoma be predicted? A retrospective analysis of 292 cases. J Neurol Surg 75:37–41
22.
Zurück zum Zitat Wada M, Yamakami I, Higuchi Y, Tanaka M, Suda S, Ono J, Saeki N (2014) Influence of antiplatelet therapy on postoperative recurrence of chronic subdural hematoma: a multicenter retrospective study in 719 patients. Clin Neurol Neurosurg 120:49–54CrossRefPubMed Wada M, Yamakami I, Higuchi Y, Tanaka M, Suda S, Ono J, Saeki N (2014) Influence of antiplatelet therapy on postoperative recurrence of chronic subdural hematoma: a multicenter retrospective study in 719 patients. Clin Neurol Neurosurg 120:49–54CrossRefPubMed
23.
Zurück zum Zitat Yamamoto H, Hirashima Y, Hamada H, Hayashi N, Origasa H, Endo S (2003) Independent predictors of recurrence of chronic subdural hematoma: results of multivariate analysis performed using a logistic regression model. J Neurosurg 98:1217–1221. doi:10.3171/jns.2003.98.6.1217 CrossRefPubMed Yamamoto H, Hirashima Y, Hamada H, Hayashi N, Origasa H, Endo S (2003) Independent predictors of recurrence of chronic subdural hematoma: results of multivariate analysis performed using a logistic regression model. J Neurosurg 98:1217–1221. doi:10.​3171/​jns.​2003.​98.​6.​1217 CrossRefPubMed
24.
Zurück zum Zitat Yeon JY, Kong D-S, Hong S-C (2012) Safety of early warfarin resumption following burr hole drainage for warfarin-associated subacute or chronic subdural hemorrhage. J Neurotrauma 29:1334–1341CrossRefPubMed Yeon JY, Kong D-S, Hong S-C (2012) Safety of early warfarin resumption following burr hole drainage for warfarin-associated subacute or chronic subdural hemorrhage. J Neurotrauma 29:1334–1341CrossRefPubMed
25.
Zurück zum Zitat Zingale A, Chibbaro S, Florio A, Distefano G, Porcaro S (1999) Management of chronic subdural hematoma in patients treated with anticoagulation. J Neurosurg Sci 43:277–284PubMed Zingale A, Chibbaro S, Florio A, Distefano G, Porcaro S (1999) Management of chronic subdural hematoma in patients treated with anticoagulation. J Neurosurg Sci 43:277–284PubMed
26.
Zurück zum Zitat Ducruet AF, Grobelny BT, Zacharia BE, Hickman ZL, DeRosa PL, Anderson K, Sussman E, Carpenter A, Connolly ES Jr (2012) The surgical management of chronic subdural hematoma. Neurosurg Rev 35:155–169 discussion 169CrossRefPubMed Ducruet AF, Grobelny BT, Zacharia BE, Hickman ZL, DeRosa PL, Anderson K, Sussman E, Carpenter A, Connolly ES Jr (2012) The surgical management of chronic subdural hematoma. Neurosurg Rev 35:155–169 discussion 169CrossRefPubMed
27.
Zurück zum Zitat Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137:263–272. doi:10.1378/chest.09-1584 CrossRefPubMed Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137:263–272. doi:10.​1378/​chest.​09-1584 CrossRefPubMed
28.
Zurück zum Zitat Cannegieter SC, Rosendaal FR, Briet E (1994) Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 89:635–641CrossRefPubMed Cannegieter SC, Rosendaal FR, Briet E (1994) Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 89:635–641CrossRefPubMed
29.
Zurück zum Zitat Chari A, Hocking K, Edlmann E, Turner C, Santarius T, Hutchinson PJ, Kolias AG (2015) Core outcomes and common data elements in chronic subdural Haematoma (CODE-CSDH): a systematic review of the literature focusing on baseline and peri-operative care data elements. J Neurotrauma. doi:10.1089/neu.2015.4248 Chari A, Hocking K, Edlmann E, Turner C, Santarius T, Hutchinson PJ, Kolias AG (2015) Core outcomes and common data elements in chronic subdural Haematoma (CODE-CSDH): a systematic review of the literature focusing on baseline and peri-operative care data elements. J Neurotrauma. doi:10.​1089/​neu.​2015.​4248
Metadaten
Titel
Association between antithrombotic drug use before chronic subdural haematoma and outcome after drainage: a systematic review and meta-analysis
verfasst von
Michael T. C. Poon
Rustam Al-Shahi Salman
Publikationsdatum
26.05.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Neurosurgical Review / Ausgabe 2/2018
Print ISSN: 0344-5607
Elektronische ISSN: 1437-2320
DOI
https://doi.org/10.1007/s10143-017-0860-x

Weitere Artikel der Ausgabe 2/2018

Neurosurgical Review 2/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.